This company seems to have been delisted
Reason: Shutdown after failing to find a buyer
Last recorded trade on: February 24, 2023
Source: https://www.fiercebiotech.com/biotech/genocea-closes-shop-after-failing-find-buyer-delists-nasdaq
Reason: Shutdown after failing to find a buyer
Last recorded trade on: February 24, 2023
Source: https://www.fiercebiotech.com/biotech/genocea-closes-shop-after-failing-find-buyer-delists-nasdaq
Genocea Biosciences
GNCA
0,00008553 €
Share price
-85.71%
Change (1 day)
N/A
Change (1 year)
Categories
Genocea Biosciences (GNCA) - Total debt
Total debt on the balance sheet as of March 2022 : €13.24 Million
According to Genocea Biosciences 's latest financial reports the company's total debt is €13.24 Million. A company’s total debt is the sum of all current and non-current debts.
Genocea Biosciences - Total debt on balance sheet (from 2012 to 2022)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2021-12-31 | €15.17 M | -21.82% |
| 2020-12-31 | €19.4 M | 9.16% |
| 2019-12-31 | €17.78 M | 37.24% |
| 2018-12-31 | €12.95 M | 8.63% |
| 2017-12-31 | €11.92 M | -26.02% |
| 2016-12-31 | €16.12 M | 6.98% |
| 2015-12-31 | €15.06 M | 59.54% |
| 2014-12-31 | €9.44 M | 33.19% |
| 2013-12-31 | €7.09 M | 131.92% |
| 2012-12-31 | €3.05 M | 1837.19% |
| 2011-12-31 | €0.15 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Agenus
AGEN | €78.72 M | 494.40% | 🇺🇸 USA |
 Novavax NVAX | €0.19 B | 1,376.65% | 🇺🇸 USA |
 Merck MRK | €29.80 B | 224,917.76% | 🇺🇸 USA |
 iBio IBIO | €3.21 M | -75.75% | 🇺🇸 USA |
 Pfizer PFE | €52.42 B | 395,708.85% | 🇺🇸 USA |